594
S.-N. Li et al. / Tetrahedron: Asymmetry 25 (2014) 591–595
a colorless oil. ½a D25
ꢁ
¼ ꢀ1:92 (c 1.01, CHCl3); 1H NMR (300 MHz,
and brine consecutively, dried over anhydrous Na2SO4, and con-
centrated. The crude product was purified by silica gel chromatog-
raphy (hexanes/ethyl acetate 5:1) to give (S)-7 (0.85 g, 87%) as a
CDCl3) d: 1.07 (s, 9H), 1.09 (s, 3H), 1.19–1.39 (m, 1H), 1.32–1.61
(m, 2H), 1.50–1.62 (m, 2H), 1.56 (s, 3H), 1.66 (s, 3H), 1.94–1.95
(m, 1H), 2.07–2.09 (m, 1H), 2.70 (s, 1H), 2.91 (d, J = 5.0 Hz, 1H),
3.47–3.52 (m, 1H), 3.76–3.84 (m, 2H), 5.03–5.07 (m, 1H), 7.37–
7.48 (m, 6H), 7.65–7.69 (m, 4H); 13C NMR (75 MHz, CDCl3) d:
17.54, 19.09, 22.07, 23.12, 25.60, 26.80, 38.05, 64.84, 73.80,
75.80, 124.23, 127.81, 129.91, 131.65, 132.53, 132.67, 135.47,
135.50; HRMS (TOF) m/z calcd for C26H35O3Si [MꢀH]+ 425.2512,
found 425.2504.
colorless oil. ½a D25
ꢁ
¼ þ2:3 (c 0.79, CHCl3), lit8
½
a 2D5
ꢁ
¼ þ3:2 (c 0.4,
CHCl3); 1H NMR (300 MHz, CDCl3) d: 1.37 (s, 3H), 1.58 (s, 3H),
1.71 (s, 3H), 1.58–1.85 (m, 2H), 1.86–1.91 (m, 1H), 2.06–2.08 (m,
1H), 2.92 (s, 1H), 2.94 (t, J = 4.9 Hz, 1H), 4.48–4.51 (m, 2H), 5.02–
5.07 (m, 1H); 13C NMR (75 MHz, CDCl3) d: 17.64, 22.16, 25.60,
26.07, 39.93, 64.66, 78.47, 122.98, 133.25, 214.15. HRMS (TOF)
m/z calcd for C10H17O3 [MꢀH]+ 185.1178, found 185.1173.
4.2.8. Synthesis of (2S,3R)-1-tert-butyldiphenylsilyloxy-3,7-
dimethyl-6-octene-2,3-diol (2S,3R)-5
4.2.12. Synthesis of (R)-1,3-dihydroxy-3,7-dimethyl-6-octen-2-
one (R)-7
According to the similar procedure described above, (2S,3R)-4
(5.6 g, 30 mmol) was converted into (2S,3R)-5 (12.03 g, 94%) as a
According to the similar procedure described above, (R)-6
(2.23 g, 5.25 mmol) was converted into (R)-7 (0.83 g, 85%) as a col-
colorless oil. ½a D25
ꢁ
¼ þ1:92 (c 1.01, CHCl3); 1H NMR (300 MHz,
orless oil. ½a 2D5
ꢁ
¼ ꢀ2:5 (c 0.79, CHCl3), lit6
½
a 2D5
ꢁ
¼ ꢀ4:0 (c 1.08,
CDCl3) d: 1.07 (s, 9H), 1.19 (s, 3H), 1.26–1.39 (m, 2H), 1.50 (s,
3H), 1.50–1.56 (m, 1H), 1.66 (s, 3H), 1.92–1.98 (m, 1H), 2.05–2.09
(m, 1H), 2.71 (s, 1H), 2.92 (d, J = 4.8 Hz, 1H), 3.49–3.52 (m, 1H),
3.79–3.81 (m, 2H), 5.03–5.05 (m, 1H), 7.37–7.45 (m, 6H), 7.66–
7.68 (m, 4H); 13C NMR (75 MHz, CDCl3) d: 17.54, 19.09, 22.07,
23.13, 25.60, 26.80, 38.05, 64.84, 73.80, 75.81, 124.24, 127.81,
129.91, 131.64, 132.54, 132.67, 135.47, 135.50; HRMS (TOF) m/z
calcd for C26H37O3Si [MꢀH]+ 425.2512 found 425.2497.
CHCl3); 1H NMR (300 MHz, CDCl3) d: 1.37 (s, 3H), 1.58 (s, 3H),
1.67 (s, 3H), 1.68–1.81 (m, 2H), 1.82–1.96 (m,1H), 2.03–2.13 (m,
1H), 3.13 (t, J = 4.9 Hz, 1H), 3.17 (s, 1H), 4.49–4.58 (m, 2H), 5.04
(t, J = 6.9 Hz, 1H); 13C NMR (75 MHz, CDCl3) d: 17.56, 22.07,
25.53, 25.93, 39.89, 64.65, 78.42, 122.96, 133.06, 214.22. HRMS
(TOF) m/z calcd for C10H17O3 [MꢀH]+ 185.1178, found 185.1177.
4.3. Improvement of the enantiomeric purity of (S)-7 and (R)-7
4.2.9. Synthesis of (S)-1-tert-butyldiphenylsilyloxy-3-hydroxy-
3,7-dimethyl-6-octen-2-one (S)-6
4.3.1. Synthesis of (S)-3-hydroxy-3,7-dimethyl-2-oxo-6-octenyl
4-bromobenzoate (S)-8
To a solution of (2R,3S)-5 (2.63 g, 6.1 mmol) in anhydrous CH2Cl2
(8 mL) at 0 °C, DMSO (22 mL), triethylamine (6 mL, 42.64 mmol)
and sulfur trioxide pyridine complex (4.86 g, 30.6 mmol) were
added sequentially. After stirring for 24 h at room temperature,
the reaction was quenched with water at 0 °C, and extracted with
CH2Cl2. The combined organic phases were successively washed
with water and brine, dried over anhydrous Na2SO4, and
concentrated. The crude product was purified by silica gel
chromatography (hexanes/ethyl acetate 5:1) to give (S)-6 (2.13 g,
To a stirred solution of (S)-7 (1.86 g, 10 mmol) and triethyl-
amine (3.1 mL, 22 mmol) in CH2Cl2 (10 mL) at 0 °C, a solution of
4-bromobenzoyl chloride (2.63 g, 12 mmol) in CH2Cl2 was added
dropwise over 15 min. After stirring overnight at room tempera-
ture, the reaction was quenched with water and extracted with
CH2Cl2. The organic phase was washed sequentially with water
and brine, dried over anhydrous Na2SO4, and concentrated. The
residue was purified by silica gel chromatography (hexanes/ethyl
acetate 10:1) to give (S)-8 (3.5 g, 95%, 86% ee) as a white solid. Slow
recrystallization of (S)-8 from hexanes-ether improved the enan-
tiomeric purity to 99% ee, and gave nearly enantiomerically pure
(S)-8 as colorless crystals. The overall yield of the parab-
romobenzoylation was 80% (2.95 g, 8 mmol). mp 85.1–85.2 °C;
82%) as
a
colorless oil.
½
a 2D5
ꢁ
¼ ꢀ0:52 (c 1.46, CHCl3), lit6
½
a 2D1
ꢁ
¼ ꢀ0:5 (c 1.46, CHCl3); 1H NMR (300 MHz, CDCl3) d: 1.07 (s,
9H), 1.09 (s, 3H), 1.51 (s, 3H), 1.54–1.74 (m, 3H), 1.63 (s, 3H),
1.96–2.01 (m, 1H), 3.46 (s, 1H), 4.52 (s, 2H), 4.93–4.99 (m, 1H),
7.36–7.47 (m, 6H), 7.65–7.68 (m, 4H); 13C NMR (75 MHz, CDCl3)
d: 17.61, 19.24, 22.08, 25.54, 25.59, 26.71, 39.46, 66.28, 78.31,
123.35, 127.82, 129.98, 132.46, 132.49, 135.51, 135.57, 135.58,
211.15. HRMS (TOF) m/z calcd for C26H35O3Si [MꢀH]+ 423.2355,
found 423.2358.
½
a 2D5
ꢁ
¼ þ5:7 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3) d: 1.44 (s,
3H), 1.62 (s, 3H), 1.67 (s, 3H), 1.71–1.84 (m, 1H), 1.85–1.92 (m,
1H), 2.00–2.05 (m, 1H), 2.11–2.16 (m, 1H), 3.06 (s, 1H), 5.07–5.15
(m, 1H), 5.15–5.27 (m, 2H), 7.58–7.63 (m, 2H), 7.93–7.97 (m,
2H); 13C NMR (75 MHz, CDCl3) d: 17.69, 22.15, 25.65, 25.91,
39.72, 65.69, 79.03, 123.20, 128.20, 128.56, 131.38, 131.81,
133.15, 165.21, 207.05; HRMS (TOF) m/z calcd for C17H22BrO4
[M+H]+ 369.0701, found 369.0684. Enantiomeric excess was deter-
mined by HPLC with a Chiralpak AD-H column (90:10 n-hexanes/
isopropanol, 1.0 mL/min, 230 nm); minor (R)-enantiomer tr = 8.2
min, major (S)-enantiomer tr = 9.0 min.
4.2.10. Synthesis of (R)-1-tert-butyldiphenylsilyloxy-3-hydroxy-
3,7-dimethyl-6-octen-2-one (R)-6
According to the similar procedure described above, (2S,3R)-5
(2.63 g, 6.1 mmol) was converted into (R)-6 (2.15 g, 83%) as a col-
orless oil. ½a 2D5
ꢁ
¼ þ0:5 (c 1.46, CHCl3), lit6
½
a 2D0
ꢁ
¼ þ0:45 (c 1.17,
CHCl3); 1H NMR (300 MHz, CDCl3) d: 1.07 (s, 9H), 1.10 (s, 3H),
1.51 (s, 3H), 1.54–1.76 (m, 3H), 1.63 (s, 3H), 1.96–2.01 (m, 1H),
3.46 (s, 1H), 4.52 (s, 2H), 4.93–4.99 (m, 1H), 7.36–7.47 (m, 6H),
7.65–7.68 (m, 4H); 13C NMR (75 MHz, CDCl3) d: 17.63, 19.26,
22.09, 25.55, 25.60, 26.72, 39.47, 66.28, 78.32, 123.36, 127.84,
130.00, 132.46, 132.50, 132.52, 135.59, 135.60, 211.16. HRMS
(TOF) m/z calcd for C26H35O3Si [MꢀH]+ 423.2355, found 423.2366.
4.3.2. Hydrolysis of (S)-8 to (S)-7
To a solution of (S)-8 (1.92 g, 5 mmol) in methanol (10 mL) at
0 °C was added NaOH (25 mL, 1 mol/L, 25 mmol). After stirring
for 3 h, the mixture was extracted with Et2O. The organic phase
was washed with brine, dried over anhydrous Na2SO4, and concen-
trated. The residue was purified by silica gel chromatography
(hexanes/ethyl acetate 5:1) to give (S)-7 (0.78 g, 84%) as a colorless
4.2.11. Synthesis of (S)-1,3-dihydroxy-3,7-dimethyl-6-octen-2-
one (CPB pheromone) (S)-7
oil. ½a 2D5
ꢁ
¼ þ3:3 (c 1.7, CHC13), lit8
½
a 2D5
ꢁ
¼ þ3:2 (c 0.4, CHCl3).
To a stirred solution of (S)-6 (2.23 g, 5.25 mmol) in THF (25 mL)
was added tetra-n-butylammonium fluoride (7.9 mL, 1.0 M in THF,
7.9 mmol) slowly at 0 °C. After the reaction mixture was main-
tained for 40 min at 0 °C, it was poured into water and extracted
with EtOAc. The combined organic phases were washed with water
4.3.3. Synthesis of (R)-3-hydroxy-3,7-dimethyl-2-oxo-6-octenyl
4-bromobenzoate (R)-8
According to the similar procedure described above, (R)-7
(1.86 g, 10 mmol) was converted into (R)-8 (2.92 g, 79%, 99% ee)
as colorless crystals. mp 85.1–85.3 °C; ½a D25
¼ ꢀ5:4 (c 1.0, CHCl3);
ꢁ